The emerging treatment of the medication represents a exciting breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide254203.get-blogging.com/42449217/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment